ST-segment elevation myocardial infarction

Area of Science:

• Cardiology
• Vascular Medicine
• Emergency Medicine

Background:

• ST-segment elevation myocardial infarction (STEMI) is a severe form of coronary artery disease, leading to significant morbidity and mortality.
• Atherosclerotic plaque rupture causing thrombotic occlusion in epicardial coronary arteries is the primary cause of STEMI.
• Effective management hinges on rapid diagnosis and reperfusion to minimize myocardial damage and subsequent heart failure.

Purpose of the Study:

• To summarize current understanding and management strategies for STEMI.
• To highlight advancements in reperfusion therapies and their impact on patient outcomes.
• To underscore the ongoing need for research into STEMI pathophysiology and novel treatments.

Main Methods:

• Review of current medical literature and clinical guidelines on STEMI management.
• Analysis of the role of primary percutaneous coronary intervention (PCI) versus fibrinolysis.
• Examination of organizational strategies for timely reperfusion, such as cardiac catheterization networks and standardized procedures.

Main Results:

• Primary PCI is the preferred reperfusion strategy for STEMI when achievable within 120 minutes of diagnosis.
• Fibrinolysis serves as an alternative when timely PCI is not feasible.
• Improved systems of care and antithrombotic therapies have reduced STEMI mortality.
• Despite advances, a significant number of patients experience recurrent cardiovascular events post-STEMI.

Conclusions:

• Timely reperfusion therapy, particularly primary PCI, is crucial for improving outcomes in STEMI patients.
• Organizational improvements and new therapeutic approaches have decreased STEMI-related mortality.
• Further research into STEMI pathophysiology is essential for developing more effective treatment strategies and reducing long-term cardiovascular events.